A CASE OF DÜHRING'S DERMATITIS HERPETIFORMIS ASSOCIATED WITH SARS - COV - 2
Clinical studies during the epidemic of a new coronavirus infection caused by SARS - CoV -2 confirm not only dermatropic skin lesions, but also complex immune-mediated skin complications of COVID -19, one of which is Dühring's herpetiform dermatitis.
To present a clinical case of Dühring's dermatitis herpetiformis, which developed against the background of a coronavirus infection, probably caused by the SARS - CoV - 2 virus.
Retrospective analysis of the medical history, interpretation of clinical and laboratory data in an 81-year-old patient with developed Duhring's dermatitis herpetiformis. Characteristic changes in the skin pathological process in a patient with Dühring's dermatitis herpetiformis made it possible to assume a tendency to a protracted severe course as a result of a coronavirus infection, leading to a protracted immunodeficiency state. The presented case will be of interest to therapists, infectious disease specialists, doctors of other specialties, as well as residents and students of medical universities.
Nurgul K. Sultanova1-2, Nurlan K. Shaimardanov1,
1 NJSC "Semey Medical University", Semey c., Republic of Kazakhstan;
2 City multidisciplinary hospital №1 of Semey city, Semey c., Republic of Kazakhstan.
1. Calvan Casas C., Catala A., Carretero Hernandez G. et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases // Br. J. Dermatol. 2020. 183:71.
2. Daneshgaran G., Dubin D.P., Gould D.J. Cutaneous Manifestations of COVID-19: An Evidence-Based Reviev // Am J Clin Dermatol. 2020. 21:627.
3. de Masson A., Bouaziz J.D., Sulimovic L. et al. Chilblains is a common cutaneous finding during the COVID-19 pandemic; A retrospective nationwide study from France // J. Am. Acad. Dermatol. 2020. 83:667.
4. Freeman E.E., McMahon D.E., Lipoff J.B. et al. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries // J Am Acad Dermatol. 2020. 83:486.
5. Freeman E.E., McMahon D.E., Fitzgerald M.E. et al. The American Academy of Dermatology COVID-19 registry: Crowdsoursing dermatology COVID-19 // J Am Acad Dermatol. 2020. 83:509.
6. Guan W.J., Ni Z.Y., Hu Y. et al. Clinical Characteristics of Cutaneous Disease 2019 in China // N Engl J Med. 2020. 382:1708.
7. Madigan L.M., Micheletti R.G., Shinkai K. How Dermatologists Can learn and Contribute at the Leading Edge of the COVID-19 Global Pandemic // JAMA Dermato.l 2020. 156:733.
8. Marzano A.V., Genovese G., Moltrasio C. et al. The clinical spectrum of COVID-19 associated cutaneous manifestations: An Italian multicenter study of 200 adult patients // JAM Acad Dermatol. 2021. 84:1356.
9. Mascitti H., Jourdain P., Bleibtreu A. et al. Prognosis of rash and chilblain-like lesions among outpatientswith COVID -19: a large cohort study // Eur J Clin Microbiol Infect Dis. 2021. 40:2243.
10. Rajan M.B., Kumar M.P., Bhardwaj A. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review // Int J Dermatol. 2020. 59:1358.
11. Recalcati S., Gianotti R., Fantini F. COVID-19: The experience from Itali // Clin Dermatol. 2021. 39:12.
12. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective // J Eur Acad Dermatol Venerol. 2020. 34:e 212.
13. Sameni F., Hajikhani B., Yaslianifard S. et al. COVID-19 and Skin Manifestations: An Overview of case Reports / Case Series and Meta-Analysis of Prevalence Studies // Front Med (Lausanne). 2020. 7:573188.
14. Sugai T., Fujita Y., Inamura E. et al. Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan a single- ctntre study // J EUR Acad Dermatol Venerol. 2022. 36:e522.
15. Tan S.W., Tam Y.C., Oh C.C. Skin manifestationsof COVID-19: A worldwide review // JAAD Int 2021. 2:119.
16. Visconti A., Bataille V., Rossi N. et al. Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection // Br J Dermatol. 2021. 184:880.
17. Visconti A., Murray B., Rossi N. et al. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in348 691 UK users of the UK ZOE COVID Study app // Br J Dermatol. 2022. 187:900.
Количество просмотров: 290
Категория статей:
Клинический случай
Библиографическая ссылка
Sultanova N.K., Shaimardanov N.K. A case of Dühring's dermatitis herpetiformis associated with SARS - CoV -2 // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 4, pp. 278-281. doi 10.34689/SH.2023.25.4.034Похожие публикации:
ACTIVATION OF OPPOSITE PROCESSES – OSTEOPOROSIS AND OSTEOGENESIS IN ANKYLOSING SPONDYLITIS USING THE CLINICAL CASES
RABIES - AN INFECTIOUS DISEASE WITH A FATAL OUTCOME (CLINICAL CASE)
ГРАНУЛЕМАТОЗНЫЙ ПОЛИАНГИИТ (ГРАНУЛЕМАТОЗ ВЕГЕНЕРА) В ПРАКТИКЕ РЕВМАТОЛОГА
ВАРИАНТ ТЕЧЕНИЯ БОЛЕЗНИ СТИЛЛА ВЗРОСЛЫХ: КЛИНИЧЕСКИЙ СЛУЧАЙ
A CASE OF DÜHRING'S DERMATITIS HERPETIFORMIS ASSOCIATED WITH SARS - COV - 2